Mechanistically, a recent in vitro study with APP695-transfected SH-SY5Y neuroblastoma cells reported that caffeine treatment decreased Aβ levels by shifting APP processing towards the non-amyloidogenic pathway with increased α- and decreased β-secretase activity [61]. The gene discussed is APP; the disease is neuroblastoma.